Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment. - Kerr CP; Grudzinski JJ; Nguyen TP; Hernandez R; Weichert JP; Morris ZS (Pharmaceutics, 2022)